Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2024TheranosticsOpen Access

Cancer-associated fibroblast spatial heterogeneity and EMILIN1 expression in the tumor microenvironment modulate TGF-β activity and CD8+ T-cell infiltration in breast cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

CHChikako HondaSKSasagu KurozumiTFTakaaki Fujii

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Honda et al. (2024) studied this question.

synapsesocial.com/papers/69dea75c210a0977fce95013https://doi.org/10.7150/thno.90627
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer2015 · 128 citations
  2. 2TGFβ suppresses CD8+ T cell expression of CXCR3 and tumor trafficking2020 · 222 citations
  3. 3The difficulty in translating the preclinical success of combined TGFβ and immune checkpoint inhibition to clinical trial2022 · 75 citations
  4. 4Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer2005 · 1,315 citations